Clinical Trial Update: Resveratrol and Human Hepatocyte Function in Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of resveratrol for hepatocyte function in liver cancer was withdrawn. The sponsor was the University of Louisville.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Louisville | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: WITHDRAWN